MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

146.03 +0.64 (+0.44%)
Official Closing Price Updated: 7:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,067,501
Open 146.45
Bid (Size) 144.75 (100)
Ask (Size) 148.17 (100)
Prev. Close 145.39
Today's Range 145.48 - 146.67
52wk Range 104.93 - 170.46
Shares Outstanding N/A
Dividend Yield 3.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BioAge Labs R&D Day: BGE-102 Phase I Shows Big hs-CRP Drops, Sets Up Cardio & DME POC Trials ↗
BioAge Labs (NASDAQ:BIOA) used its R&D Day event to provide an update on its lead program, BGE-102, an oral, brain-penetrant inhibitor of the NLRP3 inflammasome that the company is developing across... 
Via MarketBeat
News headline image
PTCT Q1 2026 Earnings Transcript ↗
PTCT Q1 2026 Earnings Transcript 
Via The Motley Fool

Performance

YTD
+5.4%
+5.4%
1 Month
-5.8%
-5.8%
3 Month
-7.0%
-7.0%
6 Month
+14.8%
+14.8%
1 Year
+34.3%
+34.3%

More News

Read More
News headline image
This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout ↗
Via Investor's Business Daily
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Case for Dividend Investors ↗
Via Chartmill
News headline image
Incyte (INCY) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Novartis Dips As Generics Take A Bite Out Of Its First-Quarter Sales ↗
Via Investor's Business Daily
News headline image
Better Pharma Dividend Stock: Novartis vs. Merck ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
Via MarketMinute
Topics Economy Intellectual Property
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
Big Pharma Deepens AI Ties. What It Means For Novo, Novartis. ↗
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
The Radiopharmaceutical Renaissance: A Deep Dive into Telix Pharmaceuticals (TLX)
Via Finterra
Topics Economy Initial Public Offering
News headline image
3 Low-Volatility ETFs for Peace of Mind in Turbulent Times ↗
Via MarketBeat
Topics ETFs
News headline image
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
Via MarketMinute
Topics Economy World Trade
News headline image
Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring
Via MarketMinute
Topics Economy Government Lawsuit
News headline image
Legend Biotech (LEGN) Q4 2024 Earnings Transcript ↗
Via The Motley Fool
Topics Earnings Economy World Trade
News headline image
Legend Biotech (LEGN) Q1 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Biogen's $5.6 Billion Acquisition of Apellis: A Strategic Pivot into Rare Kidney Diseases
Via MarketMinute
News headline image
Could Investing $10,000 in VYMI Make You a Millionaire? ↗
Via The Motley Fool
Topics ETFs Stocks
News headline image
Novartis Bets $2 Billion To Deepen Allergy Drug Pipeline ↗
Via Benzinga
News headline image
International ETFs: EEM and IEFA Offer Distinct Global ETF Choices ↗
Via The Motley Fool
Topics ETFs
News headline image
Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
Via MarketMinute
News headline image
The Second Act: A Deep-Dive into Corcept Therapeutics and the FDA Approval of Lifyorli
Via Finterra
Topics Economy Intellectual Property
News headline image
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
Via Finterra
Topics Initial Public Offering Intellectual Property World Trade
News headline image
Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF ↗
Via The Motley Fool
Topics ETFs Retirement
News headline image
3 ETFs Built for the Volatile Market We're Seeing in March 2026 ↗
Via The Motley Fool
Topics ETFs Economy Stocks

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 146.03
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 05/08/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story